Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors
Caitlyn L. Miller(Stanford University), Ronald Levy(Hôpital Necker-Enfants Malades)
Cited by 3
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation
|Nature Chemical Biology|2021|579
Targeting CD137 enhances the efficacy of cetuximab
|Journal of Clinical Investigation|2014|161